Resmed Inc.

RMD · NYSE · ·

比較

$239.53+0.2%11月13日終値

2026年9月30日までの数値（2026年10月30日提出の10-Qより）

1W: +1.8%
1M: +1.8%
3M: +7.0%

Resmed Inc.（RMD）株——良い事業でしょうか？ — InspectStocks

Resmed Inc.

RMD · NYSE · ·

比較

$239.53+0.2%11月13日終値

2026年9月30日までの数値（2026年10月30日提出の10-Qより）

1W: +1.8%
1M: +1.8%
3M: +7.0%

Just reported

Q1 FY2027 results

From Resmed's results release of 2026年10月29日; its quarterly report has since been filed.

Revenue
Actual
$1.41B
+5.9% y/y
-3.3% q/q
Guided
—
No guide given
EPS, GAAP
Actual
$2.92
+23% y/y
+11% q/q
Guided
—
No guide given
Operating income, GAAP
Actual
$453M
+1.4% y/y
+1.0% q/q
Guided
—
No guide given

Company outlook

Full year 2027

EPS, adjusted$12.00 – $12.25First given

Set against the company's own guidance and the same quarter a year earlier, not analysts' estimates, which we do not hold. Adjusted figures are the company's own non-GAAP measures, as stated in the release.

Keep exploring

The themes Resmed is part of, the highest-graded companies in its industry, and the companies in its sector whose grade rose recently.

The themes it is part of

キュレーション
Medical devices
InspectStocks 編集 · 20 companies
Surgical robots, implants, heart devices, glucose monitors and other medical equipment.
株価、1 年
+6.2%
売上、1 年
+7.2%
+14
A 8B 7C 3D 2

Highest-graded in Medical Instruments and Supplies

Graded A or B and worth $2B or more: A first, then the largest.

All 49 graded companies in its industry

Grade rose recently in Healthcare

Rose to A or B on a filing in the last 90 days, worth $2B or more: largest first.

All grade rises

どうやって稼いでいるか

Sleep and breathing devices, masks, and related products88%
Residential care software12%

売上構成比はquarter ended 2026-03-31の推計であり、提出された報告書の数字ではありません。

競合

PHGPhilips
D
規模
$29.2B
利益率
0.0%
FPHAFFisher & Paykel Healthcare

何を売っているか6

AirSense 11
A connected machine that delivers continuous or automatically adjusted air pressure to treat sleep apnea.
AirCurve 11
A bilevel breathing machine that provides different pressure levels for breathing in and out, for people needing more support or with complex breathing disorders.
Astral ventilators
Ventilators that provide breathing support, including for people receiving care at home.

さらに3件を表示

AirTouch N30i, AirTouch F30i, and AirFit F40 masks
Masks that connect a person to a breathing machine during sleep; the named models include fabric and silicone designs.
myAir and AirView
Software for patients to engage with their sleep treatment and for providers to connect with and support patients.
Brightree and MEDIFOX DAN
Software products for residential care and home medical equipment providers.

誰が買っているか3

Home medical equipment and durable medical equipment providers buy and supply devices and masks for people prescribed breathing treatment.
Residential care providers buy software such as Brightree and MEDIFOX DAN.
Patients use ResMed's breathing devices, masks, and patient software, often with support from medical equipment providers and clinicians.

何に支えられ、何に崩されうるか

事業が頼っているもの

1Manufacturing depends on electronic components and freight; the company has cited rising costs in both.
2Astral corrective work uses electronic components that are being prioritized for existing patients and device servicing.
3Sales depend on clinicians diagnosing sleep and breathing conditions and providers helping patients start and continue treatment.

うまくいかなくなる可能性

1A field safety action involving Astral ventilators requires corrective work and has led ResMed to suspend new Astral sales during fiscal 2027.
2Inflation in electronic components and freight can outpace manufacturing productivity; modest price increases may be constrained by customers' reimbursement arrangements.
3Device and mask sales depend on patients being diagnosed, prescribed treatment, and supported through setup and ongoing use.

財務諸表をすべて見る →

Resmed Inc.について

ResMed makes devices that help people breathe during sleep and ventilators for people who need breathing support. It also sells masks and software for patients, medical equipment providers, and residential care providers. Its sleep products include machines that connect with patient and provider software.

本社: San Diego, California
設立: 1989
従業員数: More than 11,000 (as of 2026-08-06, high)
上場市場: NYSE
決算期: June 30

Resmed Inc. 自身が米国証券取引委員会（SEC）に提出した書類にもとづきます。数字は報告されたままで、1 株当たりの履歴は今日の株数基準に修正済みです。これは事業の説明です——投資助言ではなく、売買を勧めるものでもありません。

Just reported